News | January 25, 2025
Merck inaugurates expansion of its Peenya facility in Bengaluru
Expansion makes Merck Life Science in Bengaluru a key manufacturing location in the APAC region
Expansion makes Merck Life Science in Bengaluru a key manufacturing location in the APAC region
PAT after MI is Rs. 41 crore which is 162% increase
Scored 85/100, 2.3x the industry average in Social and 73/100, 1.8x the industry average in Governance
The revenue from operations in Q3 FY25 is Rs. 8,358.6 crore, up 16% YoY
According to IQVIATM sales data for the 12-month period ending November 2024, the Vitamin K1 Injectable Emulsion USP, 10 mg/mL market achieved annual sales of approximately $19.7 million
The Acetaminophen and Ibuprofen tablets will be manufactured at the company’s flagship facility in KRSG, Bengaluru
Jemperli plus chemotherapy is the only immuno-oncology-based treatment to show statistically significant and clinically meaningful OS benefit in the overall population
The company ensures a reliable and strong portfolio at competitive prices without compromising on excellent quality
Datroway is the eighth new medicine of the 20 AstraZeneca has set out to deliver by 2030
SIM0500 is a humanized trispecific antibody that targets GPRC5D, BCMA, and CD3
Subscribe To Our Newsletter & Stay Updated
